Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain PARIS, March 28, 2025 (GLOBE NEWSWIRE) — Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products […]
Read more
Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint
Recent Posts
Kagamb¨ga FC Triumphs in Maracana Jeunesse Unie Tournament
September 29, 2026
Ti©b©l© Gendarmerie Facilitates Issuance of Biometric Identity Cards
September 29, 2026
Faso-Action Completes Classroom at P©ni ‘A’ Primary School
September 29, 2026